Kuros Biosciences AG (FRA:YTSN)

Germany · Delayed Price · Currency is EUR

27.76

-0.56 (-1.98%)

Last updated: Feb 20, 2026, 9:37 PM CET

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medical Devices	75.56M	33.56M	13.27M	8.34M	4.04M
Medical Devices Growth	125.11%	153.03%	59.03%	106.51%	-
Legacy Portfolio	-	-	4.72M	5.47M	-
Legacy Portfolio Growth	-	-	-13.76%	-	-
Total	75.56M	33.56M	17.99M	13.82M	4.04M
Total Growth	125.11%	86.61%	30.19%	242.04%	57.71%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
United States of America	72.84M	32.84M	17.38M	13.22M	3.95M
United States of America Growth	121.80%	88.93%	31.54%	234.90%	60.34%
European Union	746.00K	580.00K	429.00K	281.00K	27.00K
European Union Growth	28.62%	35.20%	52.67%	940.74%	-
Other	1.97M	143.00K	174.00K	319.00K	66.00K
Other Growth	1277.62%	-17.82%	-45.45%	383.33%	200.00%
Total	75.56M	33.56M	17.99M	13.82M	4.04M
Total Growth	125.11%	86.61%	30.19%	242.04%	57.71%

Source: S&P Global Market Intelligence.